Invivoscribe, a leader in precision medicine and measurable residual disease (MRD) testing, today announced the addition of the LeukoStrat® KMT2A + MRD Assay and Software to its industry-leading ...
BBVA reported a profit of €10.5 billion in 2025 (+4.5 percent yoy), the highest in its history, mostly driven by core revenues.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results